1[1]Koltai M, Hosford D, Guinot P, et al. Platelet activating Factor(PAF). A review of its effects, antagonistsand possible future clinical implications. Drugs. 1991,42:9-29
2[2]Akisu M, Kultursay N, Coker L, et al. platelet-activating factor levels in newborn infants with and withoutperinatal asphyxia:is it and additional marker of perinatal asphyxia? Acta Paediatr Jpn. 1998, 40:427-31.
3[3]Akisu M, kultursay N, Coker L, et al. The effect of Lcarnitine on platelet activating factor concentration inthe immature rat model of hypoxic-ischemic brain injury. Acta Med Okayama. 1998,52:183-7.
4[4]Liu XH, Eun BL, Siverstein FS, et al. The platelet-activating factor anlagonist BN52021 attenuates hypoxic-ischemic brain injury in the immature rat. Pediatr Res1996,40;797-803.
5[5]Yue Tl, Feuerstein GZ. Platelet-activating factor, a putative neuromodulator and mediator in the pathophysiology of brain injury. Crit Rev Neurobiol, 1994, 8:1124.
6[6]Furukawa M, lee EL, Johnston JM. Platelet-activatingfactorinduced ischemic bowel necrosis : the effect ofplatelet-activating factor acetylhydrolase, Pediatr Res,1993,34:237-41.
7[7]Hsueh W, Caplan MS, Sun X, et al. Platelet-activatingfactor, tumor necrosis factor, hypoxia and necrotizingenterocolitis. Acta Paediatr Suppl, 1994,396:11-7.
8[8]Caplan M, Hsueh W, kelly A, et al. Serm PAF acetylhydrolase increases during neonatal maturation.Prostaglandins, 1990,39:705-14.
9[9]Caplan Ms,Lickerman M,Adler L,et al. The role of recombinant platelet-activating factor acetylhydrolase in aneonatal rat model of necrotizing enterocolitis, PediatrRes, 1997,42: 779-83.
10[10]Cundell DR Gerard NP, Gerard C, et al. Strepto-coccus pneumoniae anchor to activated human cells by thereceptor for platelet-activating factor. Nature. 1995,377(6548):435-8.
